MARKET

ADXS

ADXS

Ayala Pharm
EXMKT
0.085
NaN%
Closed 09:30 12/05 EST
OPEN
--
PREV CLOSE
0.085
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
56.80
52 WEEK LOW
0.027
MARKET CAP
3.61M
P/E (TTM)
-0.0106
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ADXS last week (1124-1128)?
Weekly Report · 6d ago
Weekly Report: what happened at ADXS last week (1117-1121)?
Weekly Report · 11/24 10:05
Weekly Report: what happened at ADXS last week (1110-1114)?
Weekly Report · 11/17 10:05
Weekly Report: what happened at ADXS last week (1103-1107)?
Weekly Report · 11/10 10:03
Weekly Report: what happened at ADXS last week (1027-1031)?
Weekly Report · 11/03 10:03
Weekly Report: what happened at ADXS last week (1020-1024)?
Weekly Report · 10/27 10:06
Weekly Report: what happened at ADXS last week (1013-1017)?
Weekly Report · 10/20 10:03
Weekly Report: what happened at ADXS last week (1006-1010)?
Weekly Report · 10/13 10:05
More
About ADXS
Ayala Pharmaceuticals, Inc. is a clinical-stage oncology company primarily focused on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers, primarily in genetically defined patient populations. The Company's lead candidate is aspacytarabine (BST-236), a novel anti-metabolite for first line treatment in unfit acute myeloid leukemia (AML). Aspacytarabine (BST-236) is composed of cytarabine covalently bound to asparagine, acting as a pro-drug of cytarabine.

Webull offers Ayala Pharmaceuticals Inc stock information, including EXMKT: ADXS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ADXS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ADXS stock methods without spending real money on the virtual paper trading platform.